Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Faes Farma ( (ES:FAE) ) has shared an update.
Faes Farma, S.A. has completed the acquisition of Laboratorios Edol, a leading Portuguese ophthalmology company, as part of its strategic plan to enhance its presence in Portugal and expand its international growth. This acquisition, valued at 75 million euros, is expected to create synergies with Faes Farma’s current R&D efforts and support business growth in new therapeutic areas.
More about Faes Farma
Faes Farma, S.A. operates in the pharmaceutical industry, focusing on the development and commercialization of pharmaceutical products. The company is expanding its portfolio and market presence, particularly in the field of ophthalmology, which is a high-growth area due to factors like an aging population and increased screen use.
Average Trading Volume: 548,760
Technical Sentiment Signal: Buy
Current Market Cap: €1.34B
Learn more about FAE stock on TipRanks’ Stock Analysis page.